<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE305nnn/GSE305345/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305345</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>LINE-1 ORF1p is a Shared and Immunogenic Antigen in Cancer</name><description>In this study, we identify and characterize LINE-1 ORF1p as a shared and immunogenic cancer antigen. LINE-1 elements are normally repressed genomic sequences that can be reactivated in cancer. We demonstrate that ORF1p, a protein encoded by LINE-1, is selectively expressed in tumors and its peptides are presented on MHC class I molecules across diverse tumor types. Using public and newly generated immunopeptidomics datasets, we detect ORF1p-derived peptides in a tumor-specific manner. Functional assays confirm that these peptides can elicit IFN-γ responses from CD4+ and CD8+ T cells in vitro. These findings highlight ORF1p as a promising candidate for a broadly applicable cancer vaccine.</description><dates><publication>2026/08/14</publication></dates><accession>GSE305345</accession><cross_references><GSM>GSM9169059</GSM><GSM>GSM9169056</GSM><GSM>GSM9169066</GSM><GSM>GSM9169055</GSM><GSM>GSM9169058</GSM><GSM>GSM9169057</GSM><GSM>GSM9169052</GSM><GSM>GSM9169063</GSM><GSM>GSM9169062</GSM><GSM>GSM9169065</GSM><GSM>GSM9169054</GSM><GSM>GSM9169064</GSM><GSM>GSM9169053</GSM><GSM>GSM9169061</GSM><GSM>GSM9169060</GSM><GPL>16791</GPL><GSE>305345</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>